Topspin Fund L.p. - Net Worth and Insider Trading

Topspin Fund L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Topspin Fund L.p. owns 4 companies in total, including RAPT Therapeutics Inc (RAPT) , ORIC Pharmaceuticals Inc (ORIC) , and Constellation Pharmaceuticals Inc (CNST) among others .

Click here to see the complete history of Topspin Fund L.p.’s form 4 insider trades.

Insider Ownership Summary of Topspin Fund L.p.

Ticker	Comapny	Transaction Date	Type of Owner
RAPT	RAPT Therapeutics Inc	2019-10-30	10 percent owner
ORIC	ORIC Pharmaceuticals Inc	2020-11-04	10 percent owner
CNST	Constellation Pharmaceuticals Inc	2018-07-23	10 percent owner
		2016-09-20	10 percent owner

Topspin Fund L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Topspin Fund L.p. Ownership Network

Ownership Network List of Topspin Fund L.p.

No Data

Ownership Network Relation of Topspin Fund L.p.

Topspin Fund L.p. Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

Topspin Fund L.p. is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, Topspin Fund L.p. made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 9,000 shares made by William Ho , and a net sale of 898 shares made by Dirk G. Brockstedt .

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,898 shares of RAPT Therapeutics Inc (RAPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,898 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

RAPT Therapeutics Inc Insider Transactions

No Available Data

What does ORIC Pharmaceuticals Inc do?

Who are the key executives at ORIC Pharmaceuticals Inc?

Topspin Fund L.p. is the 10 percent owner of ORIC Pharmaceuticals Inc. Other key executives at ORIC Pharmaceuticals Inc include director & President and CEO Jacob Chacko , Chief Business Officer Pratik S Multani , and Chief Financial Officer Dominic Piscitelli .

ORIC Pharmaceuticals Inc (ORIC) Insider Trades Summary

Over the past 18 months, Topspin Fund L.p. made no insider transaction in ORIC Pharmaceuticals Inc (ORIC). Other recent insider transactions involving ORIC Pharmaceuticals Inc (ORIC) include a net sale of 134,539 shares made by Jacob Chacko , a net sale of 5,282 shares made by Dominic Piscitelli , and a net sale of 5,282 shares made by Pratik S Multani .

In summary, during the past 3 months, insiders sold 0 shares of ORIC Pharmaceuticals Inc (ORIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 145,103 shares of ORIC Pharmaceuticals Inc (ORIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 145,103 shares.

ORIC Pharmaceuticals Inc (ORIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

ORIC Pharmaceuticals Inc Insider Transactions

No Available Data

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

Topspin Fund L.p. is the 10 percent owner of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .

Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

What does Immune Design Corp do?

Who are the key executives at Immune Design Corp?

Topspin Fund L.p. is the 10 percent owner of Immune Design Corp. Other key executives at Immune Design Corp include 10 percent owner & other: General Partner Column Group Gp, Lp , 10 percent owner Column Group L P , and 10 percent owner & other: General Partner Ponoi Management, Llc .

Immune Design Corp (IMDZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immune Design Corp Insider Transactions

No Available Data

Topspin Fund L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Topspin Fund L.p.. You might contact Topspin Fund L.p. via mailing address: Three Expressway Plaza, Roslyn Heights Ny 11577.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.